Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |